Global investment bank E.F. Hutton & Co. has announced the appointment of former public company CEO Bryan Kobel as managing director.
Mr. Kobel rejoins E.F. Hutton, where he previously served as managing director and led the firm’s healthcare investment banking practice.
In a statement, Joseph T. Rallo, CEO of E.F. Hutton, commented, “Bryan brings a rare combination of healthcare capital markets experience and first-hand public company operating leadership. Having advised growth companies and led a biotechnology company through the public markets, he understands the strategic, financing and execution challenges facing healthcare issuers today. We are pleased to welcome Bryan to E.F. Hutton as we continue expanding our investment banking platform and delivering high-quality execution for our clients.”
Mr. Kobel added, “E.F. Hutton has built a powerful platform for growth companies seeking access to the public markets. I am excited to rejoin the firm and help expand its healthcare investment banking practice by delivering strategic guidance, capital markets expertise and execution support to companies across the life sciences sector.”
